Literature DB >> 14149915

METHOTREXATE DISPLACEMENT IN MAN.

D G JOHNS, J W HOLLINGSWORTH, A R CASHMORE, I H PLENDERLEITH, J R BERTINO.   

Abstract

Entities:  

Keywords:  BLOOD; CHROMATOGRAPHY; CLINICAL RESEARCH; FOLIC ACID; METABOLISM; METHOTREXATE; OXIDOREDUCTASES; RADIOISOTOPE SCANNING; TRITIUM; URINE

Mesh:

Substances:

Year:  1964        PMID: 14149915      PMCID: PMC289539          DOI: 10.1172/JCI104947

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  17 in total

1.  FOLIC ACID-DISPLACEMENT IN MAN.

Authors:  D G JOHNS; I H PLENDERLEITH
Journal:  Biochem Pharmacol       Date:  1963-10       Impact factor: 5.858

Review 2.  THE BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ACTION AND EFFECTS OF THE FOLIC ACID ANTAGONISTS.

Authors:  W C WERKHEISER
Journal:  Cancer Res       Date:  1963-09       Impact factor: 12.701

3.  Further observations on the site of action of amethopterin.

Authors:  P T CONDIT; J A MEAD
Journal:  Biochem Pharmacol       Date:  1963-01       Impact factor: 5.858

4.  The relation of folic acid reductase to aminopterin toxicity.

Authors:  W C WERKHEISER
Journal:  J Pharmacol Exp Ther       Date:  1962-08       Impact factor: 4.030

5.  Enzymic preparation of the 1,L-diastereoisomer of tetrahydrofolic acid.

Authors:  C K MATHEWS; F M HUENNEKENS
Journal:  J Biol Chem       Date:  1960-11       Impact factor: 5.157

6.  Synthetic prefolic A.

Authors:  J C KERESZTESY; K P DONALDSON
Journal:  Biochem Biophys Res Commun       Date:  1961-07-26       Impact factor: 3.575

7.  The metabolism of tritiated folic acid in man.

Authors:  D G JOHNS; S SPERTI; A S BURGEN
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808

8.  Assay of tritium activity in body fluids with use of a liquid scintillation system.

Authors:  W H LANGHAM; W J EVERSOLE; F N HAYES; T T TRUJILLO
Journal:  J Lab Clin Med       Date:  1956-05

9.  Inhibition of dihydrofolic reductase by aminopterin and amethopterin.

Authors:  M J OSBORN; M FREEMAN; F M HUENNEKENS
Journal:  Proc Soc Exp Biol Med       Date:  1958-02

10.  Persistence of amethopterin in normal mouse tissues.

Authors:  J R FOUNTAIN; D J HUTCHISON; G B WARING; J H BURCHENAL
Journal:  Proc Soc Exp Biol Med       Date:  1953-06
View more
  10 in total

Review 1.  Clinical pharmacokinetics of methotrexate.

Authors:  D D Shen; D L Azarnoff
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

2.  [Effect and istribution of methotrexate in the human organism during leukemia treatment].

Authors:  W Wilmanns; H Martin
Journal:  Klin Wochenschr       Date:  1968-03-15

3.  Megaloblastic anaemia during methotrexate treatment of psoriasis.

Authors:  P Borrie; P A Clark
Journal:  Br Med J       Date:  1966-05-28

4.  Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.

Authors:  Marc Ghannoum; Darren M Roberts; David S Goldfarb; Jesper Heldrup; Kurt Anseeuw; Tais F Galvao; Thomas D Nolin; Robert S Hoffman; Valery Lavergne; Paul Meyers; Sophie Gosselin; Tudor Botnaru; Karine Mardini; David M Wood
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-02       Impact factor: 10.614

5.  Transport characteristics of folates in cerebrospinal fluid; a study utilizing doubly labeled 5-methyltetrahydrofolate and 5-formyltetrahydrofolate.

Authors:  M Levitt; P F Nixon; J H Pincus; J R Bertino
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

6.  The in vivo distribution of methotrexate between plasma and erythrocytes.

Authors:  W H Steele; J F Stuart; J R Lawrence; C A McNeill
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

7.  Histopathological effects of methotrexate on mouse liver.

Authors:  A Baskerville; S Cox
Journal:  Br J Exp Pathol       Date:  1978-06

8.  7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate.

Authors:  S A Jacobs; R G Stoller; B A Chabner; D G Johns
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

9.  Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlates.

Authors:  W M Hryniuk; J R Bertino
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

10.  THE EFFECTS UPON HAEMOPOIESIS OF PROLONGED INTRAARTERIAL INFUSIONS OF METHOTREXATE COMBINED WITH THE INTERMITTENT ADMINISTRATION OF FOLINIC ACID: WITH OBSERVATIONS ON THE PLASMA LEVELS AND URINARY EXCRETION OF METHOTREXATE.

Authors:  D P ROSE; M R BOND; C EVANS
Journal:  Br J Cancer       Date:  1965-03       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.